Low dose iron
Pro Research Analysisby 
Searched over 200M research papers
The Efficacy and Safety of Low-Dose Iron Supplementation
Introduction to Low-Dose Iron Supplementation
Iron deficiency, with or without anemia, is a prevalent health issue affecting various populations, including women, children, the elderly, and patients undergoing hemodialysis. Low-dose iron supplementation has been explored as a strategy to address iron deficiency while minimizing adverse effects commonly associated with higher doses.
Low-Dose Iron in Women with Low Serum Ferritin
A study on premenopausal, non-pregnant women with low serum ferritin (<20 µg/L) and normal hemoglobin levels (≥120 g/L) demonstrated that a daily dose of 27 mg iron significantly increased serum ferritin and hemoglobin levels within one month, whereas a 9 mg dose did not affect iron stores 1. This suggests that while low-dose iron can improve hemoglobin levels, a slightly higher dose may be necessary to replenish iron stores effectively.
Low-Dose Iron in the Elderly
In elderly patients over 80 years old with iron-deficiency anemia, low-dose iron therapy (15 mg/day) was found to be as effective as higher doses (50 mg/day and 150 mg/day) in increasing hemoglobin and ferritin levels over two months. Importantly, lower doses were associated with fewer gastrointestinal side effects, such as abdominal discomfort and nausea 2. This indicates that low-dose iron is a viable option for managing iron-deficiency anemia in the elderly, reducing the risk of adverse effects.
Low-Dose Iron in Young Children
The BESTIRON study investigated the efficacy of a once-daily, low-dose iron regimen (3 mg/kg) in young children with nutritional iron deficiency anemia. The study found that this regimen effectively improved hemoglobin levels and iron stores over 12 weeks, with minimal adverse effects 3. This supports the use of low-dose iron as a "patient-friendly" treatment for young children, potentially improving adherence and outcomes.
Low-Dose Iron in Hemodialysis Patients
For patients undergoing maintenance hemodialysis, a proactive high-dose intravenous iron regimen was compared to a reactive low-dose regimen. The study found that the high-dose regimen was superior in reducing the need for erythropoiesis-stimulating agents and had a lower rate of primary endpoint events (nonfatal myocardial infarction, stroke, heart failure hospitalization, or death) 4. However, the low-dose regimen still provided significant benefits, suggesting that tailored dosing strategies can optimize patient outcomes.
Low-Dose Iron in Pregnant Women
A randomized controlled trial assessed the impact of a low-dose iron supplement (20 mg/day) in pregnant women. The study found that this regimen effectively prevented iron deficiency anemia and iron deficiency without causing significant gastrointestinal side effects 9. This highlights the potential of low-dose iron to maintain maternal iron status during pregnancy without the discomfort associated with higher doses.
Low-Dose Iron and DNA Damage Response
Interestingly, research has shown that even low-dose iron treatments can induce a DNA damage response in human endothelial cells within minutes. This response includes changes in RNA transcript profiles related to DNA repair and cellular stress 10. While the clinical significance of this finding requires further investigation, it underscores the need for careful consideration of iron dosing, even at low levels.
Conclusion
Low-dose iron supplementation is an effective and safer alternative to higher doses for various populations, including women, children, the elderly, and patients undergoing hemodialysis. It can improve iron status and hemoglobin levels while minimizing adverse effects. However, the potential for low-dose iron to induce a DNA damage response warrants further research to fully understand its implications. Tailored dosing strategies should be considered to optimize patient outcomes and minimize risks.
Sources and full results
Most relevant research papers on this topic
Effects of low-dose iron supplementation in women with low serum ferritin concentration.
Low-dose iron supplementation with 27 mg daily effectively corrects mild anemia and storage iron depletion in premenopausal women, while 9 mg dose does not affect iron stores.
RCTAre we giving too much iron? Low-dose iron therapy is effective in octogenarians.
Low-dose iron therapy effectively resolves iron-deficiency anemia in elderly patients and reduces adverse effects compared to higher doses.
RCT
Highly CitedLow Dose Once Daily Oral Iron Treatment of Young Children with Nutritional Iron Deficiency Anemia
Once daily oral iron therapy with ferrous sulfate or NovaFerrum for young children with nutritional iron deficiency anemia shows promising results in improving hemoglobin levels.
RCTRandomized Trial Comparing Proactive, High-Dose versus Reactive, Low-Dose Intravenous Iron Supplementation in Hemodialysis (PIVOTAL): Study Design and Baseline Data
Proactive, high-dose intravenous iron supplementation is noninferior to reactive, low-dose iron supplementation in preventing nonfatal heart attacks, strokes, and heart failure in hemodialysis patients.
RCT
Large Human TrialEffect of Micronutrient Powder (MNP) with a Low-Dose of Iron on Hemoglobin and Iron Biomarkers, and Its Effect on Morbidities in Rural Bangladeshi Children Drinking Groundwater with a High-Level of Iron: A Randomized Controlled Trial
Low-dose iron micronutrient powder effectively prevents anemia and reduces key side-effects in rural Bangladeshi children drinking high-iron groundwater.
RCTLarge Human Trial
Very Rigorous JournalLow dose daily iron supplementation improves iron status and appetite but not anemia, whereas quarterly anthelminthic treatment improves growth, appetite and anemia in Zanzibari preschool children.
Low dose daily iron supplementation improves iron status and appetite, but not anemia, while quarterly anthelminthic treatment improves growth, appetite, and anemia in Zanzibari preschool children.
RCTHighly CitedEffectiveness of low-dose iron treatment in non-anaemic iron-deficient women: a prospective open-label single-arm trial.
Low-dose iron treatment (6 mg twice daily for 8 weeks) is effective and minimally side effects in iron-deficient non-anaemic women with normal BMI and menstruation.
Intravenous Iron in Patients Undergoing Maintenance Hemodialysis
A high-dose intravenous iron regimen administered proactively was superior to a low-dose regimen in reducing the risk of nonfatal heart attacks, strokes, and heart failure in patients undergoing hemodialysis.
RCTLarge Human Trial
Rigorous JournalHighly CitedEfficacy and tolerability of low-dose iron supplements during pregnancy: a randomized controlled trial.
Low-dose iron supplements (20 mg/d) during pregnancy effectively prevent iron deficiency and anemia without causing gastrointestinal side effects.
RCTLarge Human TrialHighly CitedLow Dose Iron Treatments Induce a DNA Damage Response in Human Endothelial Cells within Minutes
Low dose iron treatments can modify the vascular endothelium and induce a DNA damage response within minutes.
In Vitro StudyRigorous Journal